Candriam SCA’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-547,953
Closed -$11.4M 911
2022
Q3
$11.4M Sell
547,953
-75,230
-12% -$1.57M 0.08% 239
2022
Q2
$12.9M Buy
+623,183
New +$11.1M 0.11% 191

Other funds holding CVET

Candriam SCA's CVET Position: Q4 2022 in Review

Candriam SCA sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 547,953 shares — an estimated $11.4M sold.

Candriam SCA first reported a position in CVET in Q2 2022 and held it in 2 quarters. The position peaked at $12.9M in Q2 2022. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Candriam SCA reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Candriam SCA sold 547,953 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $11.4M.
  • Candriam SCA first reported a position in Covetrus, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Candriam SCA's Covetrus, Inc. Common Stock position peaked at $12.9M in Q2 2022.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.